| EMA number | EMEA/H/C/002118 |
| ATC code | C09DB04 |
| Authorisation | 24 November 2011 |
| Withdrawn | 17 February 2014 |
| Revision | 2 |
Treatment of essential hypertension in adults: Add on therapy Onduarp is indicated in adults whose blood pressure is not adequately controlled on amlodipine. Replacement therapy Adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of Onduarp containing the same component doses.
TELMISARTAN AND HYDROCHLOROTHIAZIDE — ALEMBIC, approved 2023-09-12 (ANDA203010).
17,594 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.